Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 2
2020 3
2021 8
2022 11
2023 7
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Results by year

Filters applied: . Clear all
Page 1
Comparative Analysis of SARS-CoV-2 Antigenicity across Assays and in Human and Animal Model Sera.
Mühlemann B, Wilks SH, Baracco L, Bekliz M, Carreño JM, Corman VM, Davis-Gardner ME, Dejnirattisai W, Diamond MS, Douek DC, Drosten C, Eckerle I, Edara VV, Ellis M, Fouchier RAM, Frieman M, Godbole S, Haagmans B, Halfmann PJ, Henry AR, Jones TC, Katzelnick LC, Kawaoka Y, Kimpel J, Krammer F, Lai L, Liu C, Lusvarghi S, Meyer B, Mongkolsapaya J, Montefiori DC, Mykytyn A, Netzl A, Pollett S, Rössler A, Screaton GR, Shen X, Sigal A, Simon V, Subramanian R, Supasa P, Suthar M, Türeli S, Wang W, Weiss CD, Smith DJ. Mühlemann B, et al. Among authors: rossler a. bioRxiv [Preprint]. 2023 Sep 27:2023.09.27.559689. doi: 10.1101/2023.09.27.559689. bioRxiv. 2023. PMID: 37808679 Free PMC article. Preprint.
Neutralization of SARS-CoV-2 Omicron subvariant BA.2.87.1.
Lasrado N, Rössler A, Rowe M, Collier AY, Barouch DH. Lasrado N, et al. Among authors: rossler a. Vaccine. 2024 Apr 2;42(9):2117-2121. doi: 10.1016/j.vaccine.2024.03.007. Epub 2024 Mar 7. Vaccine. 2024. PMID: 38458874 Free article.
Comparison of Four SARS-CoV-2 Neutralization Assays.
Riepler L, Rössler A, Falch A, Volland A, Borena W, von Laer D, Kimpel J. Riepler L, et al. Among authors: rossler a. Vaccines (Basel). 2020 Dec 28;9(1):13. doi: 10.3390/vaccines9010013. Vaccines (Basel). 2020. PMID: 33379160 Free PMC article.
Reduced sensitivity of antibody tests after omicron infection.
Rössler A, Knabl L, Raschbichler LM, Peer E, von Laer D, Borena W, Kimpel J. Rössler A, et al. Lancet Microbe. 2023 Jan;4(1):e10-e11. doi: 10.1016/S2666-5247(22)00222-1. Epub 2022 Sep 19. Lancet Microbe. 2023. PMID: 36137554 Free PMC article. No abstract available.
Immune response after two doses of the BNT162b2 COVID-19 vaccine and risk of SARS-CoV-2 breakthrough infection in Tyrol, Austria: an open-label, observational phase 4 trial.
Seekircher L, Bánki Z, Kimpel J, Rössler A, Schäfer H, Falkensammer B, Bante D, Forer L, Schönherr S; Shieldvacc-2 Study Group; Harthaller T, Sacher M, Ower C, Tschiderer L, Ulmer H, Krammer F, von Laer D, Borena W, Willeit P. Seekircher L, et al. Among authors: rossler a. Lancet Microbe. 2023 Aug;4(8):e612-e621. doi: 10.1016/S2666-5247(23)00107-6. Epub 2023 Jun 21. Lancet Microbe. 2023. PMID: 37354911 Free PMC article. Clinical Trial.
Antiviral Potential of Azelastine against Major Respiratory Viruses.
Fischhuber K, Bánki Z, Kimpel J, Kragl N, Rössler A, Bolze A, Muellauer B, Angerer J, Nagy G, Nagy E, Szijarto V. Fischhuber K, et al. Among authors: rossler a. Viruses. 2023 Nov 23;15(12):2300. doi: 10.3390/v15122300. Viruses. 2023. PMID: 38140540 Free PMC article.
32 results